Glyset

Glyset (miglitol) is an alpha-glucosidase inhibitor used for glycemic control in type 2 diabetes. This comprehensive monograph details its mechanism of action, clinical efficacy, and practical use. Learn about the evidence-based indications, dosing strategies, and important safety considerations for this unique oral anti-diabetic agent. Let’s talk about Glyset. It’s one of those agents that never really hit the first-line superstar status of metformin or the later GLP-1s, but in my two decades of managing complex diabetes cases, it’s carved out a very specific, valuable niche.